Franklyn G Prendergast's Net Worth

$60.8 Million

Estimate Recalculated Sep 18, 2024 03:22PM EST

Who is Franklyn G Prendergast?

Franklyn G Prendergast has an estimated net worth of $60.8 Million. This is based on reported shares across multiple companies, which include LILLY ELI & CO, Immunome Inc., NeuBase Therapeutics, Inc., Lantern Pharma Inc., and CANCER GENETICS, INC.

SEC CIK

Franklyn G Prendergast's CIK is 0001233256

Past Insider Trading and Trends

2017 was Franklyn G Prendergast's most active year for acquiring shares with 5 total transactions. Franklyn G Prendergast's most active month to acquire stocks was the month of October. 2023 saw Franklyn G Prendergast paying a total of $185,928.75 for 205,065 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

LILLY ELI & CO (LLY) Snapshot price: $900.9999

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.18%
802
$83.18
$66,710.36
68.57K
Nov 20
Form 4
+3.22%
2.09K
$76.64
$160,024.32
66.9K
Nov 30
Form 4
+2.91%
1.78K
$81.23
$144,995.55
63.14K
Nov 30
Form 4
+3.74%
2.15K
$67.29
$145,009.95
59.81K
Nov 28
Form 4
+5.37%
2.84K
$51.03
$144,976.23
55.76K
Nov 29
Form 4
+6.43%
3.08K
$47.03
$144,993.49
51K
Nov 30
Form 4
+9.54%
3.99K
$36.34
$144,996.60
45.81K
Nov 30
Form 4
+11.80%
4.19K
$34.63
$144,995.81
39.68K
Nov 30
Form 4
+13.63%
4.04K
$35.89
$144,995.60
33.67K
Nov 30
Form 4
+19.21%
4.51K
$32.13
$145,002.69
28K
Nov 28
Form 4
+14.36%
2.84K
$51.06
$144,996.20
22.62K
Nov 30
Form 4
+16.18%
2.67K
$54.26
$144,982.72
19.19K
Nov 30
Form 4
+10.30%
1.5K
$50.51
$75,757.50
16.06K
Nov 30
Form 4
+5.20%
700
$56.59
$39,613.00
14.17K
Nov 30
Form 4
—
0
—
—
0
Feb 17
Form 4
+5.60%
700
—
—
13.21K
Nov 26
No matching records found

Immunome Inc. (IMNM) Snapshot price: $13.54

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
60.84K
—
—
60.84K
Oct 2
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 16
Form 3
—
0
—
—
0
No matching records found

NeuBase Therapeutics, Inc. (NBSE) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 9
Form 4
—
0
—
—
0
Aug 19
Form 4
—
0
—
—
0
Sep 9
Form 4
—
0
—
—
0
Jul 12
Form 3
—
0
—
—
0
No matching records found

Lantern Pharma Inc. (LTRN) Snapshot price: $3.65

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 4
Form 4
—
0
—
—
0
Jun 15
Form 3
—
0
—
—
0
No matching records found

CANCER GENETICS, INC (VYNT) Snapshot price: $0.177

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 23
Form 4
+25.00%
2.5K
—
—
12.5K
Sep 28
Form 4
+33.33%
2.5K
—
—
10K
Jun 7
Form 4
+50.00%
2.5K
—
—
7.5K
Oct 11
Form 4
—
0
—
—
0
May 14
Form 4/A
—
0
—
—
0
May 22
Form 4
∞
5K
—
—
5K
May 22
Form 4
—
0
—
—
0
Oct 10
Form 3
—
0
—
—
0
No matching records found